Showing results (181-190 of 523) with videos related to
Sort By:
Pageof 53
Critical Reviews in Oncology/Hematology|May 22, 2019
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisionsRoberto Iacovelli, Chiara Ciccarese, Giovanni Schinzari, et al.Cancer|May 2, 2006
Benefit of taxanes as adjuvant chemotherapy for early breast cancer: pooled analysis of 15,500 patientsEmilio Bria, Cecilia Nistico, Federica Cuppone, et al.European Journal of Cancer (Oxford, England : 1990)|October 26, 2005
Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patientsCarlo Garufi, Barbara Vanni, Anna Maria Aschelter, et al.Journal of Thoracic Disease|June 29, 2018
Do immune checkpoint inhibitors need new studies methodology?Roberto Ferrara, Sara Pilotto, Mario Caccese, et al.Anti-Cancer Drugs|November 1, 2006
Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factorsCecilia Nisticò, Federica Cuppone, Emilio Bria, et al.Journal for Immunotherapy of Cancer|May 18, 2022
Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patientsSara Bruschini, Matteo Pallocca, Eleonora Sperandio, et al.Vaccines|February 28, 2023
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic AsthmaLuigino Calzetta, Alfredo Chetta, Marina Aiello, et al.Expert Opinion on Therapeutic Targets|August 9, 2011
Emerging pathways and future targets for the molecular therapy of pancreatic cancerVanja Vaccaro, Davide Melisi, Emilio Bria, et al.Cancer|June 2, 2009
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trialsEmilio Bria, Federica Cuppone, Diana Giannarelli, et al.Translational Lung Cancer Research|January 23, 2016
Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicitySara Pilotto, Miguel Angel Molina-Vila, Niki Karachaliou, et al.Pageof 53